Avidity Biosciences Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RNA | BMY | AMGN | GILD | VRTX |
| Company | Avidity Biosciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 24.40 | 47.39 | 273.45 | 67.47 | 402.44 |
| High | 24.96 | 47.50 | 274.35 | 67.90 | 403.88 |
| Low | 23.35 | 44.37 | 267.24 | 65.09 | 393.00 |
| Last | 23.83 | 44.70 | 269.38 | 65.27 | 397.70 |
| Change | -1.26 | -4.16 | -3.63 | -1.81 | -3.06 |
| % Change | -5.02% | -8.51% | -1.33% | -2.70% | -0.76% |
| Volume | 1,247,300 | 45,069,000 | 1,794,000 | 15,171,900 | 787,600 |
| 20-Day Average Volume | 980,770 | 12,858,680 | 2,149,590 | 6,861,755 | 964,110 |
| Previous Close | 25.09 | 48.86 | 273.01 | 67.08 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.74 | 49.94 | 270.70 | 68.68 | 402.31 |
| 20-Day Raw Stochastic | 37.21% | 3.27% | 31.20% | 2.05% | 21.98% |
| 20-Day Relative Strength | 54.78% | 28.31% | 44.80% | 28.32% | 42.69% |
| Weighted Alpha | +98.27 | -34.75 | +9.12 | -23.73 | +14.87 |
| Today's Opinion | 80% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 96% Buy | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.43% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | +1.07% since 04/18/24 |
| Low | 22.24 on 04/19/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.25 on 04/19/24 |
| High | 26.02 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | +2.76% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -4.41% since 03/25/24 |
| Low | 21.56 on 04/04/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
| High | 27.66 on 04/03/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +127.60% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -7.50% since 01/25/24 |
| Low | 10.30 on 01/26/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
| High | 27.66 on 04/03/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +371.88% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +9.55% since 10/25/23 |
| Low | 4.82 on 10/31/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 341.90 on 11/16/23 |
| High | 27.66 on 04/03/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,899,704 | 90,596,128 | 144,488,960 | 81,266,176 | 102,789,152 |
| Shares Outstanding, K | 79,719 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 9,560,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -212,220,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 2,190,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -60,440,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.78 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.79 on 02/28/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 29.82 |